semaglutide bilirubin Modulation of metabolic, inflammatory and fibrotic pathways by in metabolic dysfunction-associated steatohepatitis Glutathione Semaglutide Timing: Safe Administration

Cannabis use may alter how your body responds to insulin, potentially leading to fluctuations in blood glucose levels

2025;48:zsae280

The SUSTAIN cardiovascular outcome trial programme demonstrating significant reduction in major adverse cardiovascular events in type 2 diabetes patients, and the SELECT trial demonstrating cardiovascular event reduction in obese patients without diabetes, have further established Semaglutide as a cardioprotective agent with GLP-1R-mediated cardiovascular biology extending beyond glycaemic and weight management

Choosing between oral and injectable semaglutide depends on your goals, health profile, and routine, and checking your BMI for GLP-1 treatment is often the first step in understanding whether this therapy is suitable for you